慢性乙型肝炎患者病理特征和临床客观生化指标特点及其相关性分析
The correlation analysis between the pathological characteristics and clinical biochemical indicators in 468 chronic hepatitis B patients
-
摘要: 目的：探讨慢性乙型肝炎患者（CHB）慢性乙型肝炎患者临床客观生化指标与肝脏组织病理的相关性。方法：收集2013-2015年进行肝脏组织活检的468例CHB患者的基本信息、临床客观生化指标和肝脏组织病理的结果，分析各种临床客观生化指标与肝脏组织病理的相关性。结果：炎症活动度以G2期（70.1%）为主，G4期（1.9%）和G0期（0.0%）最少；纤维化分期以S2期（40.6%）为主，S0期（9.0%）和S4期（4.3%）最少。不同年龄段患者与炎症活动度和纤维化分期均呈正相关关系（P<0.05）；随着年龄的增加，肝脏炎症和纤维化程度呈现逐渐加重的趋势。不同lgHBV-DNA与炎症活动度无相关关系（P>0.05），与纤维化分期呈正相关关系（P<0.05）。不同HBsAg水平和不同HBeAg水平与病理炎症活动度和纤维化分期均呈负相关关系（P<0.05）。不同炎症活动度患者的丙氨酸氨基转移酶（AST）、白蛋白（ALB）、谷氨酰氨基转移酶（GGT）、凝血酶原时间（PT）间和不同纤维化分期患者的AST和GGT间差异均有统计学意义（P<0.05）。结论：CHB患者的临床客观指标与肝脏组织病理有一定的相关性，患者的临床客观指标在一定程度上反映了肝脏的功能和患者的病情，有助于了解不能行肝组织活检患者的病情和抗病毒治疗的选择。Abstract: Objective: To explore the correlation between clinical objective biochemical indexes and liver tissue pathology chronic hepatitis B(CHB).Methods: The clinical data of liver tissue pathology and objective biochemical indexes in 468 CHB were collected from 2013 to 2015,the correlation of which were analyzed.Results: The inflammatory activity included G2 stage(70.1%,maxium),G4 stage (1.9%) and G0 stage(0.0%,minimum).Fibrosis stage included S2 stage(40.6%,maxium),S0 stage(9.0%) and S4 stage(4.3%,minimum).The inflammatory activity in different age patients was positively correlated with the fibrosis stage(P<0.05).With the increasing of age,the degree of liver inflammation and fibrosis gradually increased.Different lg10HBV-DNA was not corelated to the inflammatory activity(P>0.05),and positively correlated with fibrosis stage(P<0.05).Different levels of HBsAg and HBeAg were negatively correlated with the pathological inflammatory activity and fibrosis stage(P<0.05).The differences of the AST,ALB,GGT and PT between different inflammatory activity patients,and AST and GGT between different fibrosis stage patients were statistically significan(P<0.01).Conclusions: The clinical objective index in patients with CHB is correlation with the liver tissue pathology to some extent.The clinical objective index of patients can reflect the liver function and illness condition of patients to a certain extent,which can help to understand the condition of patient who cannot accept liver biopsy,and choose the antiviral treatment.
-
Key words:
- chronic hepatitis B /
- histopathology /
- inflammation grade /
- fibrosis stage
-
[1] LIANG X,BI S,YANG W,et al.Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to hepatitis B vaccination[J].Vaccine,2009,27(47):6550. [2] LIANG X,BI S,YANG W,et al.Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China[J].J Infect Dis,2009,200(1):39. [3] LU FM,ZHANG H.Management of hepatitis B in China[J].Chin Med J(Engl),2009,122(1):3. [4] 徐成润,张闽峰,郑瑞丹,等.4 200例肝穿刺组织病理与临床分析[J].肝脏,2008,13(2):115. [5] 郑建铭,施光峰,陈明泉,等.肝穿刺活体组织病理检查102例分析[J].内科理论与实践,2009,4(2):115. [6] 黄晶,陈小苹,陈学福,等.B超引导下肝穿刺活检在隐源性肝炎诊断中的临床意义[J].实用医学杂志,2010,26(13):2326. [7] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版)[J].中华肝脏病杂志,2011,19(1):15. [8] 中国中医药学会内科肝病专业委员会.病毒性肝炎中医辨证标准(试行)[J].中医杂志,1992,33(5):39. [9] 尹常健,李勇.对乙型肝炎中医病因病机的再认识[J].中医杂志,1993,34(7):431. [10] 李进.慢性乙型病毒性肝炎的病因病机与治疗[J].湖北中医杂志,2002,24(4):10. [11] 刘绍能,陶夏平,王融冰,等.慢性乙型肝炎中医病因病机演变规律研究[J].中国中医药信息杂志,2007,14(12):14. [12] 高月求,陈建杰,王灵台.从毒邪论治慢性乙型肝炎的理论探讨和临床应用[J].上海中医药杂志,2006,40(3):8. [13] 李知玉,杨大国,邓欣,等.500例不同年龄段慢性乙型肝炎病毒携带者中医证候调查[J].中医药信息,2010,27(3):1. [14] 张建军,牟振云,刘勖,等.肝癌家庭成员HBV、HCV感染的调查分析[J].中国公共卫生,2011,17(12):1089. [15] 冼永超,徐茹,杨景毅,等.慢性乙型肝炎患者血清HBV-DNA载量与肝组织病理的关系[J].中国临床医学,2007,14(3):337. [16] 柳龙根,方国平,马春明,等.乙型肝炎患者血清HBeAg和HBV-DNA载量与临床分型及病理分级分期的关系[J].临床荟萃,2004,19(24):1391. [17] 江晓华,熊自忠,许建明,等.慢性乙型肝炎患者HBV-DNA载量与肝组织病理的关系[J].安徽医科大学学报,2006,41(4):466. [18] 柯坤宇.102例慢性乙型肝炎血生化指标与病理的相关性探讨[J].福建医药杂志,2010,32(4):78. [19] 郑春梅,邓巧娟,龙尧.HBeAg阴性慢性乙型肝炎HBV-DNA、ALT水平与病理关系的探讨[J].山东医药,2010,50(16):57. [20] 王昱,万雪莲,王成宝,等.肝功能正常与轻度异常的慢性乙肝患者临床病理及免疫学指标比较分析[J].实用医学杂志,2011,27(2):248. -
点击查看大图
计量
- 文章访问数: 3875
- HTML全文浏览量: 498
- PDF下载量: 76
- 被引次数: 0
下载:
